These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26405607)

  • 1. Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer.
    Pan QZ; Tang Y; Wang QJ; Li YQ; Zhang L; Li XD; Zhao JJ; Weng DS; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
    Oncoimmunology; 2015 Sep; 4(9):e1038017. PubMed ID: 26405607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy.
    Zhou Y; Chen CL; Jiang SW; Feng Y; Yuan L; Chen P; Zhang L; Huang S; Li J; Xia JC; Zheng M
    Oncoimmunology; 2019; 8(2):e1528411. PubMed ID: 30713783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer.
    Yang X; Weng D; Pan Q; Xiang T; Yang C; Wu Z; Li M; Xie S; Tang Y; Xia J; Zhao J
    Front Immunol; 2022; 13():974487. PubMed ID: 36439119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of the efficacy of adjuvant cytokine-induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery.
    Li X; Zhou H; Huang W; Wang X; Meng M; Hou Z; Liao L; Tang W; Xie Y; Wang R; Yu H; Wang L; Zhu H; Wang W; Tan J; Li R
    Clin Transl Immunology; 2022; 11(1):e1368. PubMed ID: 35079378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection.
    Pan QZ; Zhao JJ; Yang CP; Zhou YQ; Lin JZ; Tang Y; Gu JM; Wang QJ; Li YQ; He J; Chen SP; Song MJ; Huang Y; Yang JY; Weng DS; Xia JC
    Oncoimmunology; 2020; 9(1):1752563. PubMed ID: 32363125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.
    Pan K; Guan XX; Li YQ; Zhao JJ; Li JJ; Qiu HJ; Weng DS; Wang QJ; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
    Clin Cancer Res; 2014 Jun; 20(11):3003-11. PubMed ID: 24668644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).
    Gu Y; Lv H; Zhao J; Li Q; Mu G; Li J; Wuyang J; Lou G; Wang R; Zhang Y; Huang X
    Int Immunopharmacol; 2017 Sep; 50():263-269. PubMed ID: 28711032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non-small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials.
    Xiao Z; Wang CQ; Feng JH; Zhou MH; Wang YZ; Li NN; Sun YP; Liu SY; Yao XS; Li CW; Ma B; Ding J; Chen L
    Cytotherapy; 2019 Feb; 21(2):125-147. PubMed ID: 30554868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer.
    Wang Y; Wang C; Xiao H; Niu C; Wu H; Jin H; Yao C; He H; Tian H; Han F; Li D; Han W; Xu J; Chen J; Cui J; Li W
    Cancer Med; 2017 Jan; 6(1):45-53. PubMed ID: 27790867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancer.
    Yu B; Wang J; He C; Wang W; Tang J; Zheng R; Zhou C; Zhang H; Fu Z; Li Q; Xu J
    Exp Ther Med; 2017 Jul; 14(1):831-840. PubMed ID: 28673007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
    Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
    Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immunotherapy combined with platinum-based chemotherapy prolongs survival for non-small cell lung cancer patients.
    Qian L; Ding X; Li FQ; Tian HM; Chen X; Han FJ; Wang HY; Li WQ; Niu C; Xu JT; Li ZZ; He H; Cui JW
    Neoplasma; 2023 Apr; 70(2):251-259. PubMed ID: 37005956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer.
    Zhou ZQ; Zhao JJ; Pan QZ; Chen CL; Liu Y; Tang Y; Zhu Q; Weng DS; Xia JC
    J Immunother Cancer; 2019 Aug; 7(1):228. PubMed ID: 31455411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).
    Zhao Y; Qiao G; Wang X; Song Y; Zhou X; Jiang N; Zhou L; Huang H; Zhao J; Morse MA; Hobeika A; Ren J; Lyerly HK
    Clin Transl Oncol; 2019 Jun; 21(6):721-728. PubMed ID: 30374838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy.
    Chen Y; Guo ZQ; Shi CM; Zhou ZF; Ye YB; Chen Q
    Int J Clin Exp Med; 2015; 8(5):7728-36. PubMed ID: 26221323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis.
    Zhao JJ; Zhou S; Chen CL; Zhang HX; Zhou ZQ; Wu ZR; Liu Y; Pan QZ; Zhu Q; Tang Y; Xia JC; Weng DS
    J Cancer; 2018; 9(22):4204-4214. PubMed ID: 30519321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients.
    Zhang Y; Wang S; Yang B; Lu S; Du Y; Liu H
    Cancer Biol Med; 2019 May; 16(2):350-360. PubMed ID: 31516755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells.
    Chen Y; Lin J; Guo ZQ; Lin WS; Zhou ZF; Huang CZ; Chen Q; Ye YB
    Am J Cancer Res; 2015; 5(10):3221-30. PubMed ID: 26693072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma.
    Cui J; Wang N; Zhao H; Jin H; Wang G; Niu C; Terunuma H; He H; Li W
    Int J Cancer; 2014 Jan; 134(2):342-51. PubMed ID: 23825037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.